• 1. Establishing new scaling relations on two-dimensional MXenes for CO2 electroreduction?
  Albertus D. Handoko,Khoong Hong Khoo,Teck Leong Tan,Hongmei Jin,Zhi Wei Seh J. Mater. Chem. A, 2018,6, 21885-21890
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. EWOD-driven droplet microfluidic device integrated with optoelectronic tweezers as an automated platform for cellular isolation and analysis?
  Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
• 5. Dissociation of large gaseous serine clusters produces abundant protonated serine octamer
  Jacob S. Jordan,Evan R. Williams Analyst, 2021,146, 2617-2625

• Solvents and Organic Chemicals Organic Compounds Organic nitrogen compounds Organonitrogen compounds Amines Primary amines

Introduction to BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE (CAS No. 89676-79-9)

BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE, with the chemical identifier CAS No. 89676-79-9, is a compound of significant interest in the field of pharmaceutical chemistry and medicinal research. This bicyclic amine derivative has garnered attention due to its unique structural framework and potential biological activities. The hydrochloride salt form enhances its solubility, making it more amenable for various biochemical and pharmacological studies.

The molecular structure of BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE consists of a bicyclic system with a six-membered ring fused to a five-membered ring, featuring an amine functional group at the 1-position and a hydrochloride counterion. This configuration imparts distinct steric and electronic properties that are exploited in drug design and development. The compound’s ability to interact with biological targets in novel ways has positioned it as a promising candidate for further investigation.

In recent years, there has been growing interest in bicyclic amine derivatives due to their potential applications in treating various diseases. Studies have demonstrated that such compounds can modulate enzyme activity, interact with receptor sites, and influence signaling pathways. The specific arrangement of atoms in BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE allows for fine-tuning of its pharmacological properties, making it a valuable tool in the development of new therapeutic agents.

One of the most compelling aspects of BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE is its role in preclinical research focused on neurodegenerative disorders. Preliminary studies suggest that this compound may have neuroprotective effects by inhibiting oxidative stress and modulating neurotransmitter systems. The hydrochloride salt form enhances its bioavailability, facilitating its entry into clinical trials where its efficacy and safety can be thoroughly evaluated.

The synthesis of BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE involves multi-step organic reactions that require precise control over reaction conditions to achieve high yields and purity. Advanced synthetic methodologies, such as transition metal-catalyzed cyclizations and asymmetric hydrogenations, have been employed to construct the bicyclic core efficiently. These synthetic strategies not only highlight the compound’s structural complexity but also showcase the advancements in synthetic organic chemistry that enable the production of such intricate molecules.

From a computational chemistry perspective, BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE has been subjected to extensive molecular modeling studies to understand its interactions with biological targets at the atomic level. These studies have provided insights into how the compound’s three-dimensional structure influences its binding affinity and selectivity for specific receptors or enzymes. Such knowledge is crucial for optimizing drug candidates and minimizing off-target effects.

The pharmacokinetic profile of BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE is another area of active investigation. Researchers are exploring how its physicochemical properties affect absorption, distribution, metabolism, and excretion (ADME) in vivo. Understanding these parameters is essential for determining appropriate dosing regimens and predicting drug efficacy in humans.

In conclusion, BICYCLO[2.1.1]HEXAN-1-AMINE, HYDROCHLORIDE represents a fascinating compound with significant potential in pharmaceutical research and development. Its unique structural features, combined with promising preclinical results, make it a compelling candidate for further exploration in treating neurological and other diseases.

• 2580248-69-5(3-cyclopentylbicyclo1.1.1pentan-1-amine hydrochloride)
• 279215-56-4(1-ethylcyclobutan-1-amine hydrochloride)
• 2411180-36-2(Bicyclo[3.2.0]heptan-3-amine, hydrochloride (1:1), (1α,5α)-)
• 2680537-43-1(Cyclobutanamine, 1-ethyl-3,3-dimethyl-, hydrochloride (1:1))
• 22287-35-0(Bicyclo1.1.1pentan-1-amine Hydrochloride)
• 102014-58-4(1-methylcyclopentan-1-amine hydrochloride)
• 1222098-09-0((1-ethylcyclopentyl)amine hydrochloride)
• 174886-05-6(1-methylcyclobutan-1-amine hydrochloride)
• 75934-56-4(norbornan-1-amine;hydrochloride)
• 732944-06-8(bicyclo[2.1.1]hexan-1-amine)